Business
Heating engineers urged to sign up to heat pump ‘giveaway’ for their own homes
Heating engineers across Britain are being urged to take up the offer of a government-funded heat pump to install in their own homes, as part of efforts to roll out the clean technology.
Research and innovation firm Nesta is running a “start at home” initiative to provide heating engineers with a funded heat pump and training on how to install it, so they can learn the ropes before fitting the technology for customers.
The initiative comes after a pilot scheme by Nesta found supporting heating engineers to install their first heat pump in their home boosted their technical knowledge, understanding of living with the technology, and confidence in promoting them to customers.
Experts warn large-scale deployment of clean electric-powered heat pumps is key to replacing the widespread use of gas boilers in homes to reduce carbon emissions as part of targets to cut greenhouse gases to “net zero” by 2050.
That means installing round 450,000 heat pumps in existing homes a year by 2030, requiring 38,000 more installers trained and confident to install heat pumps before then, Nesta said.
The organisation said heat pumps were more efficient than gas boilers, potentially lowering energy bills, and tend to require less maintenance and last longer, keeping homes warm for years.
But Nesta pointed to research by the Department for Energy Security and Net Zero (DESNZ) suggesting only 27% of newly trained installers have gone on to complete an installation within a year, partly due to a lack of a confidence in the technology and the process of putting it in.
So the start at home scheme is being rolled out with partners across England, Wales and Scotland, providing heat engineers with heat pumps for their own homes and expert support, and putting them on the path to the accreditation needed to install the technology for customers under government schemes.
Madeleine Gabriel, Nesta’s director of sustainable future, said: “As more and more households look to switch their home heating, it will be all hands to the pump – and we want to help ensure that Britain’s heating workforce is ready to respond.
“Although lots of heating engineers are curious about heat pumps, many rarely get the chance to see one, let alone install one.
“The ‘start at home’ scheme changes that by beginning where it makes most sense – at home.
“Our message to all heating engineers is simple: secure your future by getting hands-on with the tech with installation yourself.”
Eric MacRae, a heating engineer who took part in the pilot which ran across Scotland, added: “I have confidence now that I’ve got one running in my own property that I have 24/7 experience of.
“Instead of giving people a spiel, I can now speak from personal experience of using it myself.
“It’s giving me an extra edge, and I feel that I can emphasise more of the advantages than I previously would have been able to.”
Business
Anthropic officially designated a supply chain risk by Pentagon
The supply chain risk designation of the artificial intelligence firm is a first for a US company.
Source link
Business
FDA official calls UniQure’s gene therapy a ‘failed’ treatment for Huntington’s disease
Thomas Fuller | SOPA Images | Lightrocket | Getty Images
UniQure needs to run another study to prove that its gene therapy “actually helps people with Huntington’s disease,” a senior U.S. Food and Drug Administration official said on a call with reporters Thursday.
The official, who requested anonymity before discussing sensitive information, confirmed the agency has asked the company to run a placebo controlled trial of its treatment, which is administered directly into the brain. UniQure has said that type of study isn’t ethical because it would require putting people under general anesthesia for hours, a characterization the official disputed.
“So what is really going on? UniQure is the latest company to make a failed therapy for Huntington’s patients,” the official said. “They likely acknowledge or understand at some deep level that their trial failed years ago, and instead of doing the right thing and running the correct clinical study, UniQure is performing a distorted or manipulated comparison in the mind of FDA.”
The comments mark the latest development in a messy public spat between UniQure and the FDA, and as the agency comes under fire for a number of recent drug approval application rejections, including some where companies have accused it of going back on previous guidance. FDA Commissioner Marty Makary in an interview with CNBC’s Becky Quick last week seemingly criticized UniQure’s gene therapy for Huntington’s disease. Makary didn’t name UniQure but described its treatment.
UniQure then accused the FDA of reversing its stance that the company’s clinical trial data would be sufficient to seek approval. UniQure’s study used an outside database to measure how patients with Huntington’s disease might decline without treatment, known as an external control. UniQure has said it wouldn’t be feasible to run a true randomized, double-blind placebo-controlled study, considered the gold standard, because it wouldn’t be ethical to make people undergo a sham hours-long brain surgery.
The FDA official said the agency “never agreed to accept this distorted comparison” and the FDA “never makes such assurances.” Instead, the “FDA will always say, ‘Well, we have to see the data when we get it.'”
UniQure didn’t immediately comment.
The company’s stock rose more than 10% on Thursday and has fallen 58% this year as of Thursday afternoon.
Business
US mortgage rates rise to 6% after three-week slide as oil-driven bond yields climb – The Times of India
The average long-term US mortgage rate edged higher this week, ending a three-week decline as bond yields rose amid oil-price pressures linked to the war with Iran.The benchmark 30-year fixed mortgage rate increased to 6% from 5.98% last week, mortgage buyer Freddie Mac said on Thursday. A year ago, the average rate stood at 6.63%, AP reported.The modest uptick breaks a three-week slide in borrowing costs, with mortgage rates having hovered close to the 6% mark for most of this year. Last week’s average had marked the first time the rate dipped below 6% since September 2022, reaching its lowest level in nearly three and a half years.Mortgage rates are influenced by several factors, including the Federal Reserve’s interest-rate policy, investor expectations about inflation and economic growth, and movements in the bond market.They typically track the direction of the 10-year US Treasury yield, which lenders use as a benchmark for pricing home loans.The 10-year Treasury yield rose to 4.14% at midday Thursday, up from around 4% a week earlier.Treasury yields have moved higher in recent days as rising oil prices added fresh inflation concerns, potentially complicating the Federal Reserve’s plans to cut interest rates.
-
Politics1 week agoWhat are Iran’s ballistic missile capabilities?
-
Business7 days agoIndia Us Trade Deal: Fresh look at India-US trade deal? May be ‘rebalanced’ if circumstances change, says Piyush Goyal – The Times of India
-
Business1 week agoAttock Cement’s acquisition approved | The Express Tribune
-
Fashion1 week agoPolicy easing drives Argentina’s garment import surge in 2025
-
Politics1 week agoUS arrests ex-Air Force pilot for ‘training’ Chinese military
-
Business6 days agoGreggs to reveal trading amid pressure from cost of living and weight loss drugs
-
Sports6 days agoLPGA legend shares her feelings about US women’s Olympic wins: ‘Gets me really emotional’
-
Fashion7 days agoTexwin Spinning showcasing premium cotton yarn range at VIATT 2026
